These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 198304)

  • 1. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines.
    Terpstra C; Frenkel S; Straver PJ; Barteling SJ; van Bekkum JG
    Dev Biol Stand; 1976; 35():333-42. PubMed ID: 198304
    [No Abstract]   [Full Text] [Related]  

  • 2. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
    Bauer K
    Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evalutation of some methods of assay of foot-and-mouth disease antigen for vaccines.
    Garland AJ; Mowat GN; Fletton B
    Dev Biol Stand; 1976; 35():323-32. PubMed ID: 198302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Several criteria of evaluation of foot-and-mouth disease virus reproduced in cell cultures in suspension].
    Girard HC
    Dev Biol Stand; 1976; 35():91-6. PubMed ID: 71255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of type A foot-and-mouth disease virus subtypes by double- and radial-immunodiffusion analysis.
    Lobo CA; Cowan KM; Trautman R; Hanson RP
    Am J Vet Res; 1974 Aug; 35(8):1121-6. PubMed ID: 4368590
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibilities of biophysicochemical antigen control in vaccine production using foot-and-mouth disease virus as an example (review)].
    Liebermann H; Kwasniowski W; Strebelow G
    Arch Exp Veterinarmed; 1988 Mar; 42(2):165-73. PubMed ID: 2840042
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle.
    Pay TW; Hingley PJ
    Dev Biol Stand; 1986; 64():153-61. PubMed ID: 3025036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses.
    Rweyemamu MM; Pay TW; Parker MJ
    Dev Biol Stand; 1976; 35():205-4. PubMed ID: 198288
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparatve serological and immunological study of strains of foot-and-mouth disease virus type "O" isolated in Europe between 1963 and 1966].
    Moosbrugger GA; Leunen J; Mackowiak C; Fontaine J; Roumiantzeff M
    Bull Off Int Epizoot; 1967; 67(5):711-29. PubMed ID: 4303616
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of suspension cultures for FMD vaccine production. Criteria for the evaluation of cells, virus and vaccine.
    Nardelli L; Panina GF
    Dev Biol Stand; 1976; 35():9-25. PubMed ID: 198318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Viral particle specific serums, used in complement fixation tests of foot-and-mouth disease virus].
    Roumiantzeff M; Fayet MT
    Ann Inst Pasteur (Paris); 1969 Jun; 116(6):833-51. PubMed ID: 4312138
    [No Abstract]   [Full Text] [Related]  

  • 12. Three variants of foot-and-mouth disease virus type O: cell culture characteristics and antigenic differences.
    McVicar JW; Sutmoller P
    Am J Vet Res; 1972 Aug; 33(8):1627-33. PubMed ID: 4340052
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of antigen content and effectiveness of foor-and-mouth disease vaccines.
    Czelleng F; Sólyom F
    Dev Biol Stand; 1976; 35():295-6. PubMed ID: 198298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some problems of testing foot-and-mouth disease vaccines. II. Potency testing.
    Soós T
    Acta Vet Hung; 1987; 35(3):331-42. PubMed ID: 2829602
    [No Abstract]   [Full Text] [Related]  

  • 15. Inactivated-concentrated virus antigen for indirect complement fixation test of foot-and-mouth disease.
    Sakaki K; Suphavilai P; Chandarkeo T
    Natl Inst Anim Health Q (Tokyo); 1978; 18(3-4):128-34. PubMed ID: 216926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the correct quantitative relations of antigen components in mono-, bi- and trivalent foot-and-mouth disease vaccine preparations.
    Sólyom F; Czelleng F
    Dev Biol Stand; 1976; 35():289-94. PubMed ID: 198297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testing the activity of anti-foot-and-mouth disease vaccine in cattle: quantitative methods of antigenic extinction].
    Terré J; Stellmann C; Brun A; Favre H; Fontaine J
    Dev Biol Stand; 1976; 35():357-67. PubMed ID: 198306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast modification of foot-and-mouth disease virus by selecting clones in bovines.
    Bernal C; Balestrini J; Gomez G; Castañeda J
    Dev Biol Stand; 1976; 35():471-9. PubMed ID: 198313
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antigenic properties of some strains of foot-and-mouth disease virus].
    Bazadze TsV
    Veterinariia; 1971 Aug; 9():34-5. PubMed ID: 4334672
    [No Abstract]   [Full Text] [Related]  

  • 20. [The efficacy of foot and mouth disease vaccines after long- term storage].
    Wittmann G
    Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):33-4. PubMed ID: 6248022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.